P2.05-058 Blood Biomarkers of Inflammation, Tumor Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer: Topic: Toxicities

Corinne Faivre-Finn

P2.05-058 Blood Biomarkers of Inflammation, Tumor Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer: Topic: Toxicities

Division of Cancer Sciences (L5)

Research output: Contribution to conference › Poster › peer-review

Original language	English
Pages	S1067-S1068
Publication status	Published - Jan 2017
Event	IASLC 17th World Conference onLung Cancer - Vienna, Austria Duration: 4 Dec 2016 → 7 Dec 2017 https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S

Conference

Conference	IASLC 17th World Conference onLung Cancer
Period	4/12/16 → 7/12/17
Internet address	https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S

Keywords

biomarkers
inflammation
toxicity

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{f5d4db01797449c5aee6b57095cf3250,

title = "P2.05-058 Blood Biomarkers of Inflammation, Tumor Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer: Topic: Toxicities",

keywords = "biomarkers, inflammation, toxicity",

author = "Corinne Faivre-Finn",

year = "2017",

month = jan,

language = "English",

pages = "S1067--S1068",

note = "IASLC 17th World Conference onLung Cancer ; Conference date: 04-12-2016 Through 07-12-2017",

url = "https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S",

}

TY - CONF

T1 - P2.05-058 Blood Biomarkers of Inflammation, Tumor Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer: Topic: Toxicities

AU - Faivre-Finn, Corinne

PY - 2017/1

Y1 - 2017/1

KW - biomarkers

KW - inflammation

KW - toxicity

M3 - Poster

SP - S1067-S1068

T2 - IASLC 17th World Conference onLung Cancer

Y2 - 4 December 2016 through 7 December 2017

ER -